Samsung Biologics

Global biopharmaceutical CDMO leader based in South Korea

官网

公司概况

Samsung Biologics is one of the world's largest contract development and manufacturing organizations (CDMO) for biopharmaceuticals. Headquartered in Incheon, South Korea, the company operates the world's largest biomanufacturing capacity and serves global pharmaceutical clients including major Western pharma companies. Samsung Biologics is expanding into biosimilar development and cell & gene therapy manufacturing, positioning itself at the forefront of APAC's biotech manufacturing ecosystem.

行业
主要市场

为什么关注这家公司

三星生物制剂是全球最大的生物制剂合同开发和制造组织(CDMO),在全球制药供应链中发挥关键作用。

核心关注领域

生物制剂CDMO生物类似药细胞与基因治疗mRNA制造制药供应链

信号时间线

0 条

该公司暂无追踪信号。

信号将随官方公告被索引后出现在此处。

我们正在追踪该公司的官方渠道,信号将在发现后自动入库。